Miracle Mile Advisors LLC Purchases 308 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Miracle Mile Advisors LLC increased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 1.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,854 shares of the financial services provider’s stock after purchasing an additional 308 shares during the period. Miracle Mile Advisors LLC’s holdings in iShares Biotechnology ETF were worth $3,410,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. First Horizon Advisors Inc. raised its position in iShares Biotechnology ETF by 5.5% in the 4th quarter. First Horizon Advisors Inc. now owns 2,193 shares of the financial services provider’s stock valued at $298,000 after buying an additional 115 shares during the last quarter. Pinnacle Wealth Management Advisory Group LLC raised its position in iShares Biotechnology ETF by 8.3% in the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,931 shares of the financial services provider’s stock valued at $262,000 after buying an additional 148 shares during the last quarter. Corient Private Wealth LLC raised its position in iShares Biotechnology ETF by 1.0% in the 4th quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock valued at $11,778,000 after buying an additional 841 shares during the last quarter. Great Valley Advisor Group Inc. increased its position in shares of iShares Biotechnology ETF by 14.1% during the 4th quarter. Great Valley Advisor Group Inc. now owns 2,786 shares of the financial services provider’s stock valued at $378,000 after purchasing an additional 344 shares during the last quarter. Finally, Premier Path Wealth Partners LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $207,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.2 %

Shares of iShares Biotechnology ETF stock opened at $136.97 on Tuesday. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16. The stock has a fifty day moving average price of $134.64 and a 200-day moving average price of $134.94.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.